Eli Lilly's new oral GLP-1 medication orforglipron produced an average weight loss of 12.4% (27.3 pounds) in clinical trials.

One popular health platforms is promoting GLP-1 microdosing for weight loss: But how safe and effective is this approach?

New studies found that Americans with type 2 diabetes who are taking GLP-1 drugs like Ozempic and Mounjaro could face an ...

The weight loss conversation has been transformed in recent years by the rise of GLP-1 medications—drugs originally developed ...

Older adults with diabetes using GLP-1 receptor agonist medications may face increased risk of serious eye conditions, study ...

Doctors advise most patients on GLP-1 obesity drugs such as Wegovy and Zepbound to stay on them to keep the weight off, but ...

Uncover the truth about GLP-1 weight loss drugs like Ozempic and Mounjaro. Learn how they work, who benefits most, potential risks, and why experts say they can be game-changing tools for fighting ...

The agency shared information from reports by users of compounded semaglutide and tirzepatide who have experienced health issues.

The federal government is expected to start a 5-year-long experiment that will provide some limited coverage of obesity ...

Studies have linked GLP-1 medications to various eye conditions, some of which may lead to vision loss. Despite these ...

GLP-1 drugs, such as Ozempic and the combination drug tirzepatide also included in the study, mimic a natural hormone known as glucagon-like peptide-1 to help regulate blood sugar and insulin levels.

That means that many patients – especially those seeking weight loss treatment – had to pay for the drugs in cash. Without insurance, a 28‑day supply of brand-name GLP-1s like Ozempic ...